As of May 27
| +3.58 / +1.54%|
The 17 analysts offering 12-month price forecasts for Allergan have a median target of 287.00, with a high estimate of 400.00 and a low estimate of 238.00. The median estimate represents a +21.64% increase from the last price of 235.94.
The current consensus among 22 polled investment analysts is to Buy stock in Allergan. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.